Neuroone Medical Technologies Corp
NMTC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001500198
In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 1 sale; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Neuroone Medical Technologies Corp as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +3 vs. Q2 2024
- Shares held
- 3.62M
- −61.9K (−1.7%) vs. Q2 2024
- Total value
- $3.59M
- +$639.3K (+21.7%) vs. Q2 2024
- New holders
- 6
- 4 more added
- Sold out
- 3
- 4 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $6.21M |
| Q1 2026 | 32 | $9.14M |
| Q4 2025 | 37 | $9.44M |
| Q3 2025 | 34 | $12.8M |
| Q2 2025 | 31 | $9.80M |
| Q1 2025 | 19 | $2.63M |
| Q4 2024 | 21 | $2.30M |
| Q3 2024 | 22 | $3.59M |
| Q2 2024 | 19 | $2.95M |
| Q1 2024 | 19 | $5.16M |
| Q4 2023 | 21 | $6.81M |
| Q3 2023 | 20 | $3.71M |
| Q2 2023 | 15 | $1.79M |
| Q1 2023 | 16 | $2.44M |
| Q4 2022 | 21 | $1.53M |
| Q3 2022 | 12 | $2.99M |
| Q2 2022 | 11 | $1.51M |
| Q1 2022 | 12 | $2.33M |
| Q4 2021 | 17 | $6.52M |
| Q3 2021 | 9 | $4.94M |
| Q2 2021 | 4 | $9.36M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Neuroone Medical Technologies Corp; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 69 | $68 | 0.00% | +12+21.1% | Added |
| UBS Group AG | 108 | $107 | 0.00% | −57,195−99.8% | Reduced |
| Bank of America Corp | 229 | $227 | 0.00% | +13+6.0% | Added |
| Wells Fargo & Company | 333 | $330 | 0.00% | +333 | New |
| Nemes Rush Group LLC | 433 | $520 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,033 | $1.00K | 0.00% | +1,033 | New |
| Advisor Group Holdings, Inc. | 1,259 | $1.25K | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 2,500 | $2.48K | 0.00% | +2,500 | New |
| Tower Research Capital LLC (TRC) | 4,346 | $4.30K | 0.00% | −7,057−61.9% | Reduced |
| Virtu Financial LLC | 10,435 | $10.0K | 0.00% | −8,714−45.5% | Reduced |
| Marcum Wealth, LLC | 12,000 | $11.9K | 0.00% | +12,000 | New |
| Princeton Global Asset Management LLC | 16,833 | $16.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 26,408 | $26.1K | 0.00% | +26,408 | New |
| Northern Trust Corp | 30,281 | $30.0K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 50,000 | $49.5K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 55,556 | $55.0K | 0.00% | +55,556 | New |
| State Street Corp | 59,499 | $58.9K | 0.00% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 150,000 | $148.5K | 0.14% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 283,855 | $281.1K | 0.00% | +24,972+9.6% | Added |
| Nantahala Capital Management, LLC | 798,762 | $790.8K | 0.07% | −152,200−16.0% | Reduced |
| Vanguard Group Inc | 919,528 | $910.3K | 0.00% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 1,200,000 | $1.19M | 0.14% | +250,000+26.3% | Added |
| Mayo Clinic | 0 | $0 | 0.00% | −181,754−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −17,400−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |